Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy OraSure Technologies stock | $12.65

Own OraSure Technologies stock in just a few minutes.

Fact checked

OraSure Technologies, Inc is a medical instruments & supplies business based in the US. OraSure Technologies shares (OSUR) are listed on the NASDAQ and all prices are listed in US Dollars. OraSure Technologies employs 472 staff and has a trailing 12-month revenue of around USD$159.7 million.

How to buy shares in OraSure Technologies

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for OraSure Technologies. Find the stock by name or ticker symbol: OSUR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OraSure Technologies reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$12.65, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of OraSure Technologies, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of OraSure Technologies. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

OraSure Technologies share price

Use our graph to track the performance of OSUR stocks over time.

OraSure Technologies shares at a glance

Information last updated 2020-11-30.
Latest market closeUSD$12.65
52-week rangeUSD$5.23 - USD$19.75
50-day moving average USD$13.7715
200-day moving average USD$13.3367
Wall St. target priceUSD$19.29
PE ratio 51.35
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.2

Buy OraSure Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Forex
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, ETFs
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Bonds
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OraSure Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OraSure Technologies price performance over time

Historical closes compared with the close of $12.65 from 2020-12-09

1 week (2021-01-10) N/A
1 month (2020-12-21) 8.03%
3 months (2020-10-17) N/A
6 months (2020-07-17) N/A
1 year (2020-01-17) N/A
2 years (2019-01-17) N/A
3 years (2018-01-17) N/A
5 years (2016-01-17) N/A

Is OraSure Technologies under- or over-valued?

Valuing OraSure Technologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OraSure Technologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

OraSure Technologies's P/E ratio

OraSure Technologies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, OraSure Technologies shares trade at around 51x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

OraSure Technologies's PEG ratio

OraSure Technologies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into OraSure Technologies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

OraSure Technologies's EBITDA

OraSure Technologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$3.4 million.

The EBITDA is a measure of a OraSure Technologies's overall financial performance and is widely used to measure a its profitability.

OraSure Technologies financials

Revenue TTM USD$159.7 million
Gross profit TTM USD$94.3 million
Return on assets TTM -0.88%
Return on equity TTM -4.16%
Profit margin -8.98%
Book value $5.417
Market capitalisation USD$859.7 million

TTM: trailing 12 months

Shorting OraSure Technologies shares

There are currently 7.1 million OraSure Technologies shares held short by investors – that's known as OraSure Technologies's "short interest". This figure is 1.2% up from 7.0 million last month.

There are a few different ways that this level of interest in shorting OraSure Technologies shares can be evaluated.

OraSure Technologies's "short interest ratio" (SIR)

OraSure Technologies's "short interest ratio" (SIR) is the quantity of OraSure Technologies shares currently shorted divided by the average quantity of OraSure Technologies shares traded daily (recently around 2.1 million). OraSure Technologies's SIR currently stands at 3.34. In other words for every 100,000 OraSure Technologies shares traded daily on the market, roughly 3340 shares are currently held short.

However OraSure Technologies's short interest can also be evaluated against the total number of OraSure Technologies shares, or, against the total number of tradable OraSure Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OraSure Technologies's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 OraSure Technologies shares in existence, roughly 100 shares are currently held short) or 0.1128% of the tradable shares (for every 100,000 tradable OraSure Technologies shares, roughly 113 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against OraSure Technologies.

Find out more about how you can short OraSure Technologies stock.

OraSure Technologies share dividends

We're not expecting OraSure Technologies to pay a dividend over the next 12 months.

Have OraSure Technologies's shares ever split?

OraSure Technologies's shares were split on a 3:1 basis on 8 April 1987. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your OraSure Technologies shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for OraSure Technologies shares which in turn could have impacted OraSure Technologies's share price.

OraSure Technologies share price volatility

Over the last 12 months, OraSure Technologies's shares have ranged in value from as little as $5.23 up to $19.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OraSure Technologies's is 0.2937. This would suggest that OraSure Technologies's shares are less volatile than average (for this exchange).

OraSure Technologies overview

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, and OraSure QuickFlu Rapid Flu A&B test; OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; tuberculosis products; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 2000 and is based in Bethlehem, Pennsylvania.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site